Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 78346390Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$1.1M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#15,388
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Andrew Loring Schilb as a PI. Multi-PI records show the full award amount for context.
- 1R43AG097351-01R43Pharmacokinetics and in vivo efficacy of DA1 macrocyclic peptides in a murine model of Alzheimer's disease$576.7Kaward amount
- 1R43NS145846-01R43In vivo efficacy and in vitro toxicity assessment of peptide-based therapy HV-3 for the Treatment of Huntington's disease$490.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Andrew Loring Schilb as a PI.
FY2025 award administered by Janusq, Llc (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardJanusq, Llc
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding